TD Cowen and Cantor Fitzgerald acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HUMA:
- Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock
- Humacyte, Inc. Announces Proposed Public Offering of Common Stock
- 3 Best Stocks to Buy Now, 2/12/2024, According to Top Analysts
- Humacyte Receives FDA Priority Review for Vascular Repair Solution
- Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma